DOUGLAS C. BRYANT - 27 May 2022 Form 4 Insider Report for QUIDEL CORP /DE/ (QDEL)

Role
President & CEO, Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Douglas C. Bryant
Issuer symbol
QDEL
Transactions as of
27 May 2022
Transactions value $
$0
Form type
4
Filing time
01 Jun 2022, 16:18:29 UTC
Previous filing
07 Feb 2022
Next filing
29 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Disposed to Issuer -505,926 -100% 0 27 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -23,461 -100% $0* 0 27 May 2022 Common Stock 23,461 $15.4 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -20,249 -100% $0* 0 27 May 2022 Common Stock 20,249 $21.08 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -27,637 -100% $0* 0 27 May 2022 Common Stock 27,637 $46.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -37,440 -100% $0* 0 27 May 2022 Common Stock 37,440 $59.12 Direct F2, F4
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -30,358 -100% $0* 0 27 May 2022 Common Stock 30,358 $77.16 Direct F2, F5
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -10,593 -100% $0* 0 27 May 2022 Common Stock 10,593 $228.21 Direct F2, F6
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -8,924 -100% $0* 0 27 May 2022 Common Stock 8,924 $254 Direct F2, F7
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -11,140 -100% $0* 0 27 May 2022 Common Stock 11,140 $142.45 Direct F2, F8
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -27,043 -100% $0* 0 27 May 2022 Common Stock 27,043 $103.36 Direct F2, F9
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -18,720 -100% $0* 0 27 May 2022 Common Stock 18,720 Direct F10, F11, F12
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -7,309 -100% $0* 0 27 May 2022 Common Stock 7,309 Direct F10, F11, F13
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -2,192 -100% $0* 0 27 May 2022 Common Stock 2,192 Direct F10, F11, F13
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -7,590 -100% $0* 0 27 May 2022 Common Stock 7,590 Direct F10, F11, F14
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -2,921 -100% $0* 0 27 May 2022 Common Stock 2,921 Direct F10, F11, F15
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -3,347 -100% $0* 0 27 May 2022 Common Stock 3,347 Direct F10, F11, F16
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -27,043 -100% $0* 0 27 May 2022 Common Stock 27,043 Direct F10, F11, F17
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -24,187 -100% $0* 0 27 May 2022 Common Stock 24,187 Direct F10, F11, F18
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -2,646 -100% $0* 0 27 May 2022 Common Stock 2,646 Direct F10, F11, F13
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -794 -100% $0* 0 27 May 2022 Common Stock 794 Direct F10, F11, F13, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

DOUGLAS C. BRYANT is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2 Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3 Vested in full.
F4 28,080 shares are vested in full; 9,360 shares will vest on February 4, 2023.
F5 15,180 shares are vested in full; the remaining 15,178 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F6 3,531 shares are vested in full; the remaining 7,062 shares will vest in equal installments on August 24, 2022 and August 24, 2023.
F7 2,231 shares are vested in full; the remaining 6,693 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F8 3,713 shares will vest on July 28, 2022; 3,713 shares will vest on July 28, 2023; and 3,714 shares will vest on July 28, 2024.
F9 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F10 Each restricted stock unit represents the right to receive one share of Quidel common stock.
F11 Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F12 18,720 shares will vest on February 4, 2023.
F13 Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F14 7,590 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F15 1,460 shares will vest on August 24, 2022 and 1,461 shares will vest on August 24, 2023.
F16 1,115 shares will vest on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
F17 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F18 12,093 shares will vest on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F19 794 shares will vest on January 31, 2023.